Clinical Trials on Melanoma, Experimental
Total 3292 results
-
Rafik BatroussyNot yet recruiting
-
Peking University Cancer Hospital & InstituteRecruiting
-
Dermatologic Cooperative Oncology GroupRecruiting
-
University of TwenteNot yet recruitingMelanoma (Skin)Netherlands
-
Providence Health & ServicesMerck Sharp & Dohme LLC; Eisai Inc.RecruitingMelanoma, UvealUnited States
-
Herlev and Gentofte HospitalDanish Cancer SocietyRecruiting
-
University of California, San FranciscoMerck Sharp & Dohme LLCRecruitingMelanoma | Advanced MelanomaUnited States
-
University of Colorado, DenverNational Comprehensive Cancer Network; Taiho Oncology, Inc.RecruitingMalignant MelanomaUnited States
-
Quanli GaoNot yet recruiting
-
Inge Marie SvaneTechnical University of DenmarkRecruiting
-
Nanjing Leads Biolabs Co.,LtdRecruiting
-
A.J.M. van den EertweghIdera Pharmaceuticals, Inc.Recruiting
-
InxMed (Shanghai) Co., Ltd.RecruitingMetastatic MelanomaUnited States, Australia
-
Centre Hospitalier Universitaire de NiceRecruitingMetastatic MelanomaFrance
-
Aivita Biomedical, Inc.Recruiting
-
Universitair Ziekenhuis BrusselRecruitingMalignant MelanomaBelgium
-
Centre Hospitalier Universitaire VaudoisActive, not recruitingMetastatic MelanomaSwitzerland
-
Providence Health & ServicesPrometheus LaboratoriesActive, not recruitingMetastatic MelanomaUnited States
-
Masonic Cancer Center, University of MinnesotaCompleted
-
The Netherlands Cancer InstituteCopenhagen University Hospital at HerlevActive, not recruitingMetastatic MelanomaNetherlands, Denmark
-
St. Jude Children's Research HospitalSchering-PloughActive, not recruitingMalignant MelanomaUnited States
-
Lokon Pharma ABPrecision Oncology LLCCompletedMalignant MelanomaSweden, United States
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLCTerminated
-
Institut de Cancérologie de LorraineCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; National Cancer Institute (NCI); MedarexCompleted
-
Iovance Biotherapeutics, Inc.Active, not recruitingMetastatic MelanomaUnited States, Spain, Germany, United Kingdom, France, Hungary, Italy, Switzerland
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI); NCIC Clinical Trials Group; Children's Oncology... and other collaboratorsActive, not recruitingMelanoma (Skin)United States, Canada, Australia, South Africa
-
OHSU Knight Cancer InstituteCompleted
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; SWOG Cancer Research...CompletedMelanoma (Skin)United States
-
Immodulon Therapeutics LtdTerminatedMalignant MelanomaUnited Kingdom
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Novartis PharmaceuticalsTerminated
-
F. Stephen Hodi, MDMedImmune LLCCompletedMetastatic MelanomaUnited States
-
The Christie NHS Foundation TrustNational Institute for Health Research, United KingdomTerminatedMetastatic MelanomaUnited Kingdom
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Linkoeping UniversityKarolinska Institutet; Region Östergötland; Region Stockholm; Kronoberg County... and other collaboratorsCompleted
-
BiocadActive, not recruitingMelanoma | Melanoma MetastaticRussian Federation, Belarus
-
Netherlands Working Group on Immunotherapy of OncologyHoffmann-La Roche; Amsterdam UMC, location VUmc; The Netherlands Cancer InstituteTerminated
-
Ludwig Institute for Cancer ResearchTerminated
-
Ludwig Institute for Cancer ResearchCancer Research Institute (CRI)CompletedMalignant MelanomaUnited States
-
Ludwig Institute for Cancer ResearchTerminated
-
CHU de ReimsCompletedMetastatic MelanomaFrance
-
Bristol-Myers SquibbCompleted
-
University of UtahCompletedMelanoma (Skin)United States
-
4SC AGCompletedMalignant MelanomaGermany, Italy
-
Hospices Civils de LyonCompletedMetastatic MelanomaFrance
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia, Brazil, Spain, South Africa, Ukraine, Bosnia and Herzegovina
-
Nektar TherapeuticsImaginAb, Inc.Withdrawn
-
OncoImmune, Inc.National Cancer Institute (NCI); Huntsman Cancer InstituteWithdrawnMetastatic MelanomaUnited States